PHASE I CLINICAL TRIAL TO EVALUATE THE FEASIBILITY, SAFETY, AND CLINICAL EFFICACY OF TGFβ-RESISTANT ILIRα2-CAR T CELLS FOR TREATMENT OF RECURRENT GLIOBLASTOMA

PIs: Christine Brown, Ph.D.
Professor, Department of Hematology and Hematopoietic Cell Transplantation and Immuno-Oncology
City of Hope

Darya Alizadeh, Ph.D.
Assistant Research Professor, Department of Hematology and Hematopoietic Cell Transplantation and Immuno-Oncology
City of Hope